Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Centrosome | 7 | 2021 | 28 | 2.750 |
Why?
|
| E2F Transcription Factors | 6 | 2019 | 9 | 1.960 |
Why?
|
| E2F3 Transcription Factor | 8 | 2021 | 11 | 1.680 |
Why?
|
| Breast Neoplasms | 6 | 2021 | 1426 | 1.390 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2013 | 6 | 1.230 |
Why?
|
| Receptor, erbB-2 | 3 | 2015 | 122 | 1.040 |
Why?
|
| Mitosis | 5 | 2021 | 97 | 0.950 |
Why?
|
| Cell Movement | 2 | 2021 | 545 | 0.790 |
Why?
|
| Protein Kinases | 1 | 2021 | 91 | 0.770 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 71 | 0.630 |
Why?
|
| Chromatin | 2 | 2018 | 164 | 0.600 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 430 | 0.570 |
Why?
|
| Gene Silencing | 2 | 2015 | 143 | 0.550 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 2128 | 0.540 |
Why?
|
| DNA | 1 | 2018 | 549 | 0.510 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 287 | 0.490 |
Why?
|
| Cell Cycle Proteins | 5 | 2019 | 220 | 0.460 |
Why?
|
| Cell Cycle | 6 | 2014 | 309 | 0.460 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2009 | 200 | 0.440 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 756 | 0.430 |
Why?
|
| Retinoblastoma Protein | 6 | 2007 | 27 | 0.420 |
Why?
|
| Chromosomal Instability | 3 | 2021 | 21 | 0.420 |
Why?
|
| Transcription Factors | 5 | 2014 | 653 | 0.410 |
Why?
|
| Mice | 14 | 2021 | 5668 | 0.410 |
Why?
|
| Animals | 17 | 2021 | 14307 | 0.400 |
Why?
|
| Genes, ras | 1 | 2010 | 22 | 0.380 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 25 | 0.380 |
Why?
|
| Cyclin D1 | 1 | 2010 | 42 | 0.380 |
Why?
|
| Centrioles | 1 | 2009 | 2 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2009 | 30 | 0.360 |
Why?
|
| Female | 12 | 2021 | 19873 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 781 | 0.350 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1149 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2021 | 1802 | 0.320 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 283 | 0.290 |
Why?
|
| Fibroblasts | 6 | 2014 | 252 | 0.280 |
Why?
|
| Humans | 12 | 2021 | 34853 | 0.280 |
Why?
|
| Aneuploidy | 2 | 2021 | 20 | 0.260 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 522 | 0.260 |
Why?
|
| DNA Replication | 2 | 2014 | 148 | 0.240 |
Why?
|
| E2F2 Transcription Factor | 5 | 2007 | 7 | 0.230 |
Why?
|
| Epithelial Cells | 2 | 2021 | 366 | 0.230 |
Why?
|
| E2F1 Transcription Factor | 5 | 2007 | 17 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 968 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 2 | 2000 | 162 | 0.210 |
Why?
|
| Mice, SCID | 1 | 2021 | 143 | 0.200 |
Why?
|
| Phosphorylation | 5 | 2020 | 878 | 0.190 |
Why?
|
| Antigens, CD | 1 | 2020 | 116 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 242 | 0.190 |
Why?
|
| ras Proteins | 1 | 2000 | 49 | 0.190 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1999 | 2 | 0.190 |
Why?
|
| Survival Analysis | 1 | 2021 | 322 | 0.190 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 247 | 0.190 |
Why?
|
| Thyroid Neoplasms | 1 | 2000 | 35 | 0.190 |
Why?
|
| Chromosome Deletion | 1 | 1999 | 52 | 0.180 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 112 | 0.180 |
Why?
|
| Retina | 1 | 2002 | 255 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 122 | 0.180 |
Why?
|
| Apoptosis | 5 | 2014 | 1317 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 121 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 161 | 0.170 |
Why?
|
| Mice, Knockout | 7 | 2014 | 897 | 0.160 |
Why?
|
| Sonication | 1 | 2018 | 15 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2013 | 834 | 0.160 |
Why?
|
| Phenotype | 2 | 2015 | 650 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2013 | 392 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 166 | 0.150 |
Why?
|
| S Phase | 3 | 2013 | 36 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 336 | 0.150 |
Why?
|
| Genotype | 2 | 2015 | 641 | 0.140 |
Why?
|
| Transfection | 2 | 2015 | 496 | 0.140 |
Why?
|
| Tumor Burden | 1 | 2015 | 79 | 0.140 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 19 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2015 | 323 | 0.130 |
Why?
|
| RNA Interference | 1 | 2015 | 225 | 0.130 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 31 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2010 | 1442 | 0.130 |
Why?
|
| Lentivirus | 1 | 2013 | 20 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 96 | 0.120 |
Why?
|
| Autophagy | 1 | 2014 | 111 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 185 | 0.110 |
Why?
|
| Cell Division | 3 | 2003 | 296 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 608 | 0.110 |
Why?
|
| Embryo, Mammalian | 2 | 2003 | 152 | 0.110 |
Why?
|
| Time Factors | 2 | 2015 | 1681 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2014 | 306 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 209 | 0.110 |
Why?
|
| Prognosis | 1 | 2014 | 707 | 0.100 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2010 | 2 | 0.100 |
Why?
|
| Cell Line | 3 | 2009 | 1289 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2009 | 46 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2006 | 54 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2014 | 351 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 396 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 391 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2003 | 859 | 0.070 |
Why?
|
| Male | 3 | 2021 | 18870 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 84 | 0.060 |
Why?
|
| Mutation | 3 | 2007 | 1023 | 0.060 |
Why?
|
| Cyclin E | 1 | 2003 | 13 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 24 | 0.060 |
Why?
|
| DNA Repair | 2 | 2014 | 181 | 0.060 |
Why?
|
| Fetal Death | 1 | 2002 | 15 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2003 | 88 | 0.050 |
Why?
|
| Placenta | 1 | 2003 | 91 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2003 | 130 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2000 | 14 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2000 | 22 | 0.050 |
Why?
|
| Gamma Rays | 1 | 2000 | 25 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 27 | 0.050 |
Why?
|
| Doxycycline | 1 | 2000 | 30 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 42 | 0.050 |
Why?
|
| Oncogene Proteins v-mos | 1 | 1999 | 1 | 0.050 |
Why?
|
| Leukemia Virus, Murine | 1 | 1999 | 3 | 0.050 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 1999 | 5 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2000 | 44 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 1999 | 58 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2000 | 52 | 0.050 |
Why?
|
| Cell Transformation, Viral | 1 | 1999 | 29 | 0.050 |
Why?
|
| Flavonoids | 1 | 2000 | 78 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 480 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 1999 | 423 | 0.040 |
Why?
|
| DNA Damage | 2 | 2014 | 341 | 0.040 |
Why?
|
| Pregnancy | 1 | 2002 | 1503 | 0.040 |
Why?
|
| Cyclin G2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Gene Targeting | 2 | 2007 | 39 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 1530 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 42 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 80 | 0.030 |
Why?
|
| Homozygote | 1 | 2014 | 75 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2004 | 156 | 0.030 |
Why?
|
| Rats | 1 | 2000 | 3261 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 550 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1490 | 0.030 |
Why?
|
| G1 Phase | 1 | 2006 | 32 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 2004 | 51 | 0.020 |
Why?
|
| Retroviridae | 1 | 2004 | 22 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2004 | 59 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 32 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2004 | 139 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2004 | 132 | 0.020 |
Why?
|
| Plasmids | 1 | 2004 | 233 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2003 | 5 | 0.010 |
Why?
|
| Trophoblasts | 1 | 2003 | 22 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 642 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 605 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 103 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 203 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 118 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 484 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 580 | 0.010 |
Why?
|
| Cyclins | 1 | 2001 | 35 | 0.010 |
Why?
|
| Integrases | 1 | 2001 | 27 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 913 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2001 | 172 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 420 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1152 | 0.010 |
Why?
|